We are delighted to invite you to read the latest "A seat, a voice, a vote: reimagining the role of SMA patient advocates in research and care” by Rare Revolution Magazine.
We are delighted to invite you to read the latest 20 Years of SMA Europe: From firefighting to future-building by Rare Revolution Magazine.
We are delighted to invite you to read the latest Two decades of discovery: SMA research, from darkness to hope by Rare Revolution Magazine.
We are pleased to share a community letter from Roche, announcing that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update to the European label for the risdiplam tablet.